Morgan GJ - Search Results

1

Rees-Unwin KS, Morgan GJ, Davies FE. Rees-Unwin KS, et al. Among authors: morgan gj. Clin Lab Haematol. 2004 Apr;26(2):77-86. doi: 10.1111/j.1365-2257.2004.00598.x. Clin Lab Haematol. 2004. PMID: 15053800 Review.

2

Detection and quantitation of the CBFbeta/MYH11 transcripts associated with the inv(16) in presentation and follow-up samples from patients with AML.

Evans PA, Short MA, Jack AS, Norfolk DR, Child JA, Shiach CR, Davies F, Tobal K, Liu Yin JA, Morgan GJ. Evans PA, et al. Among authors: morgan gj. Leukemia. 1997 Mar;11(3):364-9. doi: 10.1038/sj.leu.2400578. Leukemia. 1997. PMID: 9067575

3

Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage.

Rawstron AC, Owen RG, Davies FE, Johnson RJ, Jones RA, Richards SJ, Evans PA, Child JA, Smith GM, Jack AS, Morgan GJ. Rawstron AC, et al. Among authors: morgan gj. Br J Haematol. 1997 Apr;97(1):46-55. doi: 10.1046/j.1365-2141.1997.72653.x. Br J Haematol. 1997. PMID: 9136941 Free article.

4

p53 gene mutations in multiple myeloma.

Owen RG, Davis SA, Randerson J, Rawstron AC, Davies F, Child JA, Jack AS, Morgan GJ. Owen RG, et al. Among authors: morgan gj. Mol Pathol. 1997 Feb;50(1):18-20. doi: 10.1136/mp.50.1.18. Mol Pathol. 1997. PMID: 9208809 Free PMC article.

5

The use of biological variables to predict outcome in multiple myeloma.

Davies FE, Jack AS, Morgan GJ. Davies FE, et al. Among authors: morgan gj. Br J Haematol. 1997 Dec;99(4):719-25. Br J Haematol. 1997. PMID: 9432013 Free article. Review. No abstract available.

6

B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors.

Rawstron AC, Davies FE, Owen RG, English A, Pratt G, Child JA, Jack AS, Morgan GJ. Rawstron AC, et al. Among authors: morgan gj. Br J Haematol. 1998 Jan;100(1):176-83. doi: 10.1046/j.1365-2141.1998.00525.x. Br J Haematol. 1998. PMID: 9450807 Free article.

7

Trisomy 12 is seen within a specific subtype of B-cell chronic lymphoproliferative disease affecting the peripheral blood/bone marrow and co-segregates with elevated expression of CD11a.

Su'ut L, O'Connor SJ, Richards SJ, Jones RA, Roberts BE, Davies FE, Fegan CD, Jack AS, Morgan GJ. Su'ut L, et al. Among authors: morgan gj. Br J Haematol. 1998 Apr;101(1):165-70. doi: 10.1046/j.1365-2141.1998.00661.x. Br J Haematol. 1998. PMID: 9576197 Free article.

8

Modern molecular diagnostics and the management of haematological malignancies.

Morgan GJ, Pratt G. Morgan GJ, et al. Clin Lab Haematol. 1998 Jun;20(3):135-41. doi: 10.1046/j.1365-2257.1998.00141.x. Clin Lab Haematol. 1998. PMID: 9681227 Review.

9

Evolution of treatment strategies in multiple myeloma.

Owen RG, Morgan GJ. Owen RG, et al. Among authors: morgan gj. Clin Lab Haematol. 1998 Aug;20(4):199-206. doi: 10.1046/j.1365-2257.1998.00174.x. Clin Lab Haematol. 1998. PMID: 9777264 Review. No abstract available.

10

The changing incidence of lymphoproliferative disorders in Yorkshire.

Jack AS, Morgan GJ, Clayden D, McNally R, Thomas J, Cartwright R. Jack AS, et al. Among authors: morgan gj. Clin Lab Haematol. 1998 Oct;20(5):289-95. doi: 10.1046/j.1365-2257.1998.00159.x. Clin Lab Haematol. 1998. PMID: 9807676

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

706 results

Search Page

Filters